Hypertensive crises: Diagnosis and management in the emergency room

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 4, 2004, Pages 143-152

  Migneco, A ^a   Ojetti, V ^a   De Lorenzo, A ^b   Gentiloni Silveri, N ^a   Savi, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Hypertension; Hypertensive complication; Hypertensive crises; Hypertensive emergency; Hypertensive urgency; Treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; CLONIDINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRILAT; ESMOLOL; FENOLDOPAM; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; MONOAMINE OXIDASE INHIBITOR; NICARDIPINE; NITROPRUSSIDE SODIUM; OPIATE; OXYGEN; PHENTOLAMINE; PROPRANOLOL; UNINDEXED DRUG; URAPIDIL;

ACUTE DISEASE; AORTA DISSECTION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRONCHOSPASM; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INTOXICATION; DRUG MECHANISM; DRUG TOLERANCE; ECLAMPSIA; EMERGENCY TREATMENT; EMERGENCY WARD; EMPIRICISM; EVIDENCE BASED MEDICINE; FLUSHING; HEADACHE; HEART BLOCK; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPERTENSIVE CRISIS; HYPOKALEMIA; HYPOTENSION; KIDNEY FAILURE; LUNG EDEMA; MALIGNANT HYPERTENSION; MEDICAL LITERATURE; NAUSEA; ORGAN INJURY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; STROKE; SWEAT GLAND DISEASE; TACHYCARDIA; TREATMENT PLANNING; VOMITING;

ANTIHYPERTENSIVE AGENTS; EMERGENCY SERVICE, HOSPITAL; HUMANS; HYPERTENSION; INJECTIONS, INTRAVENOUS;

EID: 10644276028     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Bales A. Hypertensive crisis. How to tell if it's an emergency or an urgency. Postgrad Med 1999; 105: 119-126, 130.
2. Zampaglione B, Pascale C, Marchisio M, Santoro A. The use of lacidipine in the management of hypertensive crises: a comparative study with nifedipine. J Cardiovasc Pharmacol 1994; 23 (Suppl 5): S116-118.
3. Gifford R. Management of hypertensive crises. JAMA 1991; 226: 829-835.
4. Finnerty FA. Hypertensive encephalopathy. Am J Med 1972; 52: 672-78.
5. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
6. Vidt DG. Emergency room management of hypertensive urgencies and emergencies. J Clin Hypertens (Greenwich) 2001; 3: 158-64.
7. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996; 27: 144-147.
8. Khanna A, McCullough PA. Malignant hypertension presenting as hemolysis, thrombocytopenia and renal failure. Rev Cardiovasc Med 2003; 4: 255-259.
9. Tuncel M, Ram VC. Hypertensive emergencies: etiology and management. Am J Cardiovasc Drugs 2003; 3: 21-31.
10. Epstein M. Diagnosis and management of hypertensive emergencies. Clin Cornestone 1999; 2: 41-54.
11. Shayne PH, Pitts SR. Severely increased blood pressure in the emergency department. Ann Emerg Med 2003; 41: 513-529.
12. Soldini M, Carmenini E, Liguori A, Baratta P, Curcio D, Giancaspro G. Guidelines for the management of hypertensive crises and simple blood pressure rise. Literature review and clinical experience. Clin Ter 2002; 153: 329-333.
13. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356: 411-417.
14. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 2001; 14 (11 Pt 1): 1154-1167.
15. Okada M, Matsumori A, Ono K, et al. Cyclic stretch up-regulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 894-901.
16. Grossman E, Hironi AN, Messerli FH. Comparative tolerability profile of hypertensive crisis treatments. Drug Saf 1998; 19: 99-122.
17. Staangaard S, Paulson OB. Cerebral blood flow in untreated and treated hypertension. Neth J Med 1995; 47: 180-184.
18. Calhoun DA, Oparil S. Treatment of hypertensive crises. N Engl J Med 1990; 323: 1177-1183.
19. Cotter G, Moshkovitz Yaron, Milovanov Olga, et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Failure 2002; 4: 227-234.
20. Orth H, Ritz E. Sodium depletion in accelerated hypertension. N Engl J Med 1975; 292: 1133.
21. Hirschl MM. Guidelines for the drug treatment of hypertensive crises. Drugs 1995; 50: 991-1000.
22. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43: 461-467.
23. Philips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension 1994; 23: 131-136.
24. Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056-1083.
25. Bath P. High blood pressure as risk factor and prognostic predictor in acute ischaemic stroke: when and how to treat it? Cerebrovascular Dis 2004; 17 (Suppl 1): 51-57.
26. No Authors Listed. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28: 2109-2118.
27. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-915.
28. Kraus JJ, Metzler MD, Coplin WM. Critical care issues in stroke and subarachnoid hemorrhage. Neurol Res 2002; 24 (Suppl 1): S47-S57.
29. Sen J, Belli A, Albon H, Morgan Laleh, Petzold A, Kitchen N. Triple-H therapy in the management of aneurismal subarachnoid haemorrhage. Lancet Neurol 2003; 2: 614-621.
30. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001; 57: 18-24.
31. Alijotas-Reig J, Bove-Farre I, DE Cabo-frances F, Angles-Coll R. Effectiveness and safety of prehospital urapidil for hypertensive emergencies. Am J Em Med 2001; 19: 130-133.
32. Pavy-Letrahon A, Costes-Salon MC, Galiner M, Fourcade J, Larrue V. Dynamics of cerebral blood flow autoregulation in hypertensive patients. J Neurol Sci 2002; 195: 139-144.
33. Eames PJ, Blake MJ, Panerai RB, Potter JF. Cerebral autoregulation indices are unimpaired by hypertension in middle aged and older people. Am J Hyperten 2003; 16: 746-753.
34. Shannon AW, Harrigan RA. General pharmacologic treatment of acute myocardial infarction. Emerg Med Clin North Am 2001; 19: 417-431.
35. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand 2004? J Am Coll Cardiol 2004; 44: 276-286.
36. Pollack CV, Gibler WB. 2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians. Ann Emerg Med 2001; 38: 229-240.
37. Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2002; 23: 1809-1840.
38. No Authors Listed. Metoprolol in acute myocardial infarction. Patient population. The MIAMI Trial Research Group. Am J Cardiol 1985; 56: 10G-14G.
39. No Authors Listed. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1988; 1(8591): 921-923.
40. Garg J, Messerli AW, Bakris GL. Evaluation and treatment of patients with systemic hypertension. Circulation 2002; 105: 2458-2461.
41. Jhund PS, Davie AP, McMurray JJV. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol 2001; 37: 1234-1238.
42. Khan IA, Chandra KN. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002; 122: 311-328.
43. Chen K, Varon J, Wenker OC, Judge DK, Fromm RE, Sternbach GL. Acute thoracic aortic dissection: the basics. J Emerg Med 1997; 15: 859-867.
44. Lipstein H, Lee CC, Crupi RS. A current concept of eclampsia. Am J Emerg Med 2003; 21: 223-226.
45. Lopez-Llera M. Main clinical subtypes of eclampsia. Am J Obstet Gynecol 1992; 166: 4-9.
46. Witlin AG, Sibai BM. Magnesium sulphate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92: 883-889.
47. Lip Gyh, Edmunds E, Leong Li Saw Hee F, Blann AD, Beevers DG. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 2001; 14: 823-828.
48. Lip Gyh, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13: 915-924.
49. Collidge TA, Lammie GA, Fleming S, Mullins JJ. The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Progr Biophys Mol Biol 2004; 84: 301-319.
50. Brouwers FM, Lenders JWM, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endoc Metabol Disord 2003; 4: 121-128.
51. Zimmerman JL. Poisonings and overdose in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794-2801.